BKS Advisors’s DexCom DXCM Stock Holding History

BKS Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$238K	Buy	+8,000	New	+$281K	0.1%	184

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BKS Advisors's DXCM Position: Q1 2019 in Review

BKS Advisors opened a new position in DexCom (DXCM) in Q1 2019: 8,000 shares worth $238K. The stake represents 0.1% of the portfolio and ranks #184 among its holdings.

456 funds tracked by Wall St. Rank hold DXCM as of Q1 2019.

BKS Advisors held 8,000 shares of DexCom worth $238K as of Q1 2019.
DexCom was a new BKS Advisors position in Q1 2019.
DexCom made up 0.1% of BKS Advisors's portfolio in Q1 2019, its #184 holding.
456 funds tracked by Wall St. Rank held DexCom as of Q1 2019.

Based on BKS Advisors's 13F filing for Q1 2019, filed 16 Apr 2019.